Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPONECK: F-Miso PET/Scan and MRI in Squamous Cell Carcinoma of the Oropharynx
NCT04031534Phase 2Completed
- Sponsor
- Centre Henri Becquerel
- Start
- Mar 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoromisonidazole in squamous cell carcinoma of the oropharynx (OPSCC), sponsored by Centre Henri Becquerel. Started Mar 2019; status: completed.
02
Drugs
fluoromisonidazole
03
Conditions
squamous cell carcinoma of the oropharynx (OPSCC)
Beyond the preview
Go deeper on NCT04031534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04031534.